Hydroxproline Catabolism and Hyperoxaluria

羟脯氨酸分解代谢和高草酸尿症

基本信息

  • 批准号:
    7783704
  • 负责人:
  • 金额:
    $ 27.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Primary hyperoxaluria types I and 2 (PH1 and PH2) are characterized by an inability to efficiently metabolize glyoxylate as a consequence of functional defects in alanine-glyoxylate aminotransferase and glyoxylate reductase, respectively. Excessive oxalate synthesis results and may ultimately cause renal failure. To date, there are no therapies that can specifically reduce oxalate synthesis. Hydroxyproline metabolism is the only recognized source of glyoxylate that has been identified to date. We hypothesize that the breakdown of dietary and endogenous hydroxyproline contributes to the bulk of the oxalate synthesized in PH1 and PH2 patients. Confirmation of this hypothesis would suggest that the inhibition of hydroxyproline degradation may be a significant therapeutic opportunity for diminishing endogenous oxalate production in PH patients. As a first step toward testing this hypothesis, we have synthesized homogeneously labeled 13C-hydroxyproline and verified that it can be used to follow the degradation of hydroxyproline to oxalate, glycolate, lactate, and glycine using chromatographic techniques coupled to mass detection. The specific aims of the proposed research are: (1) to quantitate the contribution of hydroxyproline metabolism to endogenous oxalate synthesis in normal human subjects and patients with PH using homogeneously-labeled Hyp, 13C5-hydroxyproline, as a metabolic tracer; (2) to quantitate the contribution of hydroxyproline metabolism to endogenous oxalate synthesis in mouse KO models of PH (Agxt and Grhpr KO) using 13C5-hydroxyproline. Through the quantitation and tracking of the isotopic label within metabolites, we will be able to demonstrate whether or not hydroxyproline degradation contributes to endogenous glycolate, and oxalate synthesis. Moreover, the mouse data will benchmark the contribution of hydroxyproline to urinary glycolate and oxalate in each genetic setting. This latter data will be invaluable for the future testing of therapeutics targeting the unique enzymes of the hydroxyproline degradation pathway. PUBLIC HEALTH RELEVANCE: The synthesis of oxalate, a key component of kidney stones, is influenced by glyoxylate levels. Glyoxylate is produced from hydroxyproline during the normal degradation of collagen within the body and that consumed in the diet. The purpose of this study is to determine whether or not hydroxyproline degradation contributes adversely to the elevated levels of glyoxylate and oxalate production observed in primary hyperoxaluria patients.
描述(由申请人提供):原发性高尿酸I型和2型(PH 1和PH 2)的特征在于分别由于丙氨酸-乙醛酸氨基转移酶和乙醛酸还原酶的功能缺陷而不能有效代谢乙醛酸。过量的草酸盐合成导致并可能最终导致肾衰竭。迄今为止,还没有可以特异性减少草酸盐合成的疗法。羟脯氨酸代谢是迄今为止已确定的唯一公认的乙醛酸来源。我们推测,膳食和内源性羟脯氨酸的分解有助于PH 1和PH 2患者合成的草酸盐的大部分。这一假设的证实表明,羟脯氨酸降解的抑制可能是减少PH患者内源性草酸盐产生的重要治疗机会。作为检验这一假设的第一步,我们合成了均匀标记的13 C-羟脯氨酸,并验证了它可用于使用色谱技术结合质量检测来跟踪羟脯氨酸降解为草酸盐、乙醇酸盐、乳酸盐和甘氨酸。本研究的具体目的是:(1)用13 C5-羟脯氨酸作为代谢示踪剂,定量测定正常人和PH患者体内羟脯氨酸代谢对内源性草酸合成的贡献;(2)在PH的小鼠KO模型中定量羟脯氨酸代谢对内源性草酸合成的贡献,(Agxt和Grhpr KO)。通过定量和跟踪代谢产物中的同位素标记,我们将能够证明羟脯氨酸降解是否有助于内源性乙醇酸和草酸合成。此外,小鼠数据将基准羟脯氨酸尿乙醇酸和草酸在每个遗传设置的贡献。后者的数据将是非常宝贵的未来测试的治疗靶向羟脯氨酸降解途径的独特酶。 公共卫生相关性:肾结石的关键成分草酸盐的合成受乙醛酸水平的影响。乙醛酸是由羟脯氨酸在体内胶原蛋白的正常降解过程中产生的,并在饮食中消耗。本研究的目的是确定羟脯氨酸降解是否对原发性高尿酸患者中观察到的乙醛酸和草酸盐产生水平升高产生不利影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROSS P HOLMES其他文献

ROSS P HOLMES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROSS P HOLMES', 18)}}的其他基金

Influence of Obesity on Endogenous Oxalate Synthesis
肥胖对内源性草酸合成的影响
  • 批准号:
    10167931
  • 财政年份:
    2018
  • 资助金额:
    $ 27.83万
  • 项目类别:
Influence of Obesity on Endogenous Oxalate Synthesis
肥胖对内源性草酸合成的影响
  • 批准号:
    10265575
  • 财政年份:
    2018
  • 资助金额:
    $ 27.83万
  • 项目类别:
Mitochondrial Metabolism in Primary Hyperoxaluria
原发性高草酸尿症的线粒体代谢
  • 批准号:
    8926129
  • 财政年份:
    2014
  • 资助金额:
    $ 27.83万
  • 项目类别:
12th International Symposium on Urolithiasis
第12届国际尿石症研讨会
  • 批准号:
    8319718
  • 财政年份:
    2012
  • 资助金额:
    $ 27.83万
  • 项目类别:
DIETARY FRUCTOSE AND URINARY OXALATE EXCRETION
膳食果糖和尿草酸盐排泄
  • 批准号:
    8167038
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hydroxproline Catabolism and Hyperoxaluria
羟脯氨酸分解代谢和高草酸尿症
  • 批准号:
    8075595
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
INFLUENCE OF GLYCINE BLOOD CONCENTRATION ON ITS METABOLISM TO OXALATE
甘氨酸血液浓度对其草酸盐代谢的影响
  • 批准号:
    8167055
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Ninth International Primary Hyperoxaluria Workshop
第九届国际原发性高草酸尿症研讨会
  • 批准号:
    8007053
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hydroxproline Catabolism and Hyperoxaluria
羟脯氨酸分解代谢和高草酸尿症
  • 批准号:
    8299599
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
OXIDATION OF PHENYLALANINE TO OXALATE
苯丙氨酸氧化成草酸盐
  • 批准号:
    7951419
  • 财政年份:
    2009
  • 资助金额:
    $ 27.83万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 27.83万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了